At Dana-Farber/Boston Children's Cancer and Blood Disorders Center, we are committed to providing exceptional care for children with endocrine tumors. Our Endocrine-Oncology Program brings together experts in Endocrinology, Oncology, Surgery, and Cancer Genetics, to provide exceptional, coordinated care to patients diagnosed with endocrine tumors. Because we are one of the largest pediatric cancer centers in the world, our specialists develop a deeper expertise in each sub-type of endocrine tumor, than is possible at most other cancer centers.
Our Endocrine-Oncology Program has the expertise to diagnose and treat a wide range of tumors and conditions, including:
* Children with thyroid carcinoma are treated by an integrated multi-disciplinary team in the Boston Children's Hospital’s Thyroid Program.
We use a multidisciplinary approach to patient care and work closely to coordinate our efforts with the Divisions of Pediatric Oncology, Surgery, and Endocrinology.
Junne Kamihara, MD, PhD
Pediatric Oncology, Pediatric Cancer Genetic Risk Program
Dr. Kamihara received her medical degree from Harvard Medical School and her PhD in genetics from MIT. She completed her pediatric residency training at Boston Children's Hospital and her fellowship in pediatric hematology/oncology at the Dana-Farber Cancer Institute and Boston Children's Hospital. She is currently an attending physician at Dana-Farber/Boston Children's in pediatric oncology. Her research and clinical interests focus on pediatric cancer predisposition syndromes.
Brent R. Weil, MD
Dr. Weil received his medical degree from Ohio State University School of Medicine. He completed his surgical residency training at Indiana University School of Medicine and his fellowship in pediatric general surgery at Boston Children's Hospital. He is currently an attending physician at Dana-Farber/Boston Children's and in the Department of Surgery at Boston Children's Hospital. His research and clinical interests focus on pediatric surgical oncology.
Ari J. Wassner, MD
Dr. Wassner attended Harvard Medical School and completed residency training in pediatrics at Boston Children's Hospital, where he also served as Chief Resident. He subsequently completed a subspecialty fellowship training in pediatric endocrinology at Boston Children's Hospital. He is Director of the Thyroid Program at Boston Children's Hospital, and his research and clinical interests focus on tumors of the thyroid and other endocrine organs in children.
Sarah Cochrane, MS, LGC
Lead Genetic Counselor for the Endocrine-Oncology Program
Sarah received her Master of Science in genetic counseling from Boston University School of Medicine. She has been practicing as a genetic counselor since then, seeing both adult and pediatric patients with predispositions to cancers and tumors. Her research and clinical interests focus on investigating disparities in access to cancer genetics services and integrating genetic testing into routine care for patients with cancers and tumors.
The Endocrine-Oncology team also includes a dedicated nurse practitioner and additional genetic counselors:
Phone: 617-632-5508Online form: Request an appointment
U.S. News & World Report ranked Dana-Farber/Boston Children's the #1 pediatric cancer hospital in the nation.
A genetic test can explain why a child or young adult developed cancer and can help predict whether he is at risk for other conditions.